GB201403183D0 - Detection of neurodegenerative disease - Google Patents

Detection of neurodegenerative disease

Info

Publication number
GB201403183D0
GB201403183D0 GBGB1403183.5A GB201403183A GB201403183D0 GB 201403183 D0 GB201403183 D0 GB 201403183D0 GB 201403183 A GB201403183 A GB 201403183A GB 201403183 D0 GB201403183 D0 GB 201403183D0
Authority
GB
United Kingdom
Prior art keywords
detection
neurodegenerative disease
neurodegenerative
disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GBGB1403183.5A
Other versions
GB2507705A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Exeter
Original Assignee
University of Exeter
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Exeter filed Critical University of Exeter
Publication of GB201403183D0 publication Critical patent/GB201403183D0/en
Publication of GB2507705A publication Critical patent/GB2507705A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/17Systems in which incident light is modified in accordance with the properties of the material investigated
    • G01N21/1717Systems in which incident light is modified in accordance with the properties of the material investigated with a modulation of one or more physical properties of the sample during the optical investigation, e.g. electro-reflectance
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/17Systems in which incident light is modified in accordance with the properties of the material investigated
    • G01N21/21Polarisation-affecting properties
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896Neurological disorders, e.g. Alzheimer's disease
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/17Systems in which incident light is modified in accordance with the properties of the material investigated
    • G01N21/1717Systems in which incident light is modified in accordance with the properties of the material investigated with a modulation of one or more physical properties of the sample during the optical investigation, e.g. electro-reflectance
    • G01N2021/1727Magnetomodulation
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/17Systems in which incident light is modified in accordance with the properties of the material investigated
    • G01N21/21Polarisation-affecting properties
    • G01N2021/218Measuring properties of electrooptical or magnetooptical media
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/79Transferrins, e.g. lactoferrins, ovotransferrins
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/28Neurological disorders
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/28Neurological disorders
    • G01N2800/2814Dementia; Cognitive disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Neurology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurosurgery (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
GB1403183.5A 2011-08-26 2012-08-23 Detection of neurodegenerative disease Withdrawn GB2507705A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB201114733A GB201114733D0 (en) 2011-08-26 2011-08-26 Detection of neurodegenerative disease
PCT/GB2012/052064 WO2013030542A1 (en) 2011-08-26 2012-08-23 Detection of neurodegenerative disease

Publications (2)

Publication Number Publication Date
GB201403183D0 true GB201403183D0 (en) 2014-04-09
GB2507705A GB2507705A (en) 2014-05-07

Family

ID=44838732

Family Applications (2)

Application Number Title Priority Date Filing Date
GB201114733A Ceased GB201114733D0 (en) 2011-08-26 2011-08-26 Detection of neurodegenerative disease
GB1403183.5A Withdrawn GB2507705A (en) 2011-08-26 2012-08-23 Detection of neurodegenerative disease

Family Applications Before (1)

Application Number Title Priority Date Filing Date
GB201114733A Ceased GB201114733D0 (en) 2011-08-26 2011-08-26 Detection of neurodegenerative disease

Country Status (2)

Country Link
GB (2) GB201114733D0 (en)
WO (1) WO2013030542A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2566995B (en) 2017-09-29 2023-01-18 Cotton Mouton Diagnostics Ltd A method of detection

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004105744A1 (en) * 2003-05-30 2004-12-09 Assistance Publique - Hopitaux De Paris Use of iron for treating attention deficit hyperactivity disorder in children
WO2011141766A1 (en) * 2010-05-11 2011-11-17 University Of Calcutta Ferritin biosensor and methods of using the same

Also Published As

Publication number Publication date
GB2507705A (en) 2014-05-07
GB201114733D0 (en) 2011-10-12
WO2013030542A1 (en) 2013-03-07

Similar Documents

Publication Publication Date Title
HK1209793A1 (en) Methods of detecting diseases or conditions
GB2487375B (en) Interest point detection
ZA201307591B (en) Micro-devices for disease detection
GB201205160D0 (en) State detection
EP2751929A4 (en) Proximity sensor
EP2662260A4 (en) Travel situation detection system
SI2776416T1 (en) Pharmaceutical compounds
EP2728302A4 (en) Proximity sensor
EP2707710A4 (en) Diagnosis of cancer
EP2788755A4 (en) Arrangement for detection of hemolysis
EP2688748A4 (en) Drop detection
HK1201534A1 (en) Pharmaceutical compounds
GB201119799D0 (en) Pharmaceutical compounds
EP2731610A4 (en) Pharmaceutical combination
GB201118876D0 (en) Pharmaceutical compounds
GB201113163D0 (en) Pharmaceutical compounds
ZA201308343B (en) Detection of saxitoxin-producing dinoflagellates
GB201122231D0 (en) Proximity sensor
EP2742352A4 (en) Detection of sex steroids
PL2695298T3 (en) Proximity sensor
GB201403183D0 (en) Detection of neurodegenerative disease
GB201117142D0 (en) Detection system
GB201111469D0 (en) Detection of diagnstic peptides
GB201102416D0 (en) Imaging of objects
IL228629A0 (en) Cancer detection

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)